Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech
Autor: | Serge Pinto, Pierre Pollak, Alim-Louis Benabid, Valérie Fraix, Paul Krack, Michèle Gentil, Paul Sauleau |
---|---|
Přispěvatelé: | Neurosciences précliniques, Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de neurologie, Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble, Service de neurologie [Rennes], Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Département de neurochirurgie, Savasta, Marc, Université de Rennes (UR) |
Jazyk: | angličtina |
Rok vydání: | 2005 |
Předmět: |
Parkinson's disease
Parkinsonian Disorders/*physiopathology/*therapy Stimulation Audiology Severity of Illness Index Functional Laterality Levodopa Dysarthria 0302 clinical medicine Motor speech Language disorder MESH: Levodopa MESH: Middle Aged 05 social sciences Middle Aged Dysarthria/*etiology Subthalamic nucleus surgical procedures operative Neurology Levodopa/*adverse effects medicine.symptom Subthalamic Nucleus/*physiopathology/radiation effects Psychology therapeutics medicine.drug Adult medicine.medical_specialty Electric Stimulation Therapy/*adverse effects MESH: Dysarthria MESH: Electric Stimulation Therapy Electric Stimulation Therapy 050105 experimental psychology 03 medical and health sciences Parkinsonian Disorders Subthalamic Nucleus MESH: Severity of Illness Index medicine [SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular Biology otorhinolaryngologic diseases Humans 0501 psychology and cognitive sciences [SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular Biology MESH: Functional Laterality MESH: Subthalamic Nucleus Dyskinesias MESH: Humans MESH: Parkinsonian Disorders MESH: Dyskinesias MESH: Adult medicine.disease nervous system diseases Aphonia nervous system Neurology (clinical) 030217 neurology & neurosurgery Dyskinesias/etiology |
Zdroj: | Movement Disorders, Vol. 20, No 11 (2005) pp. 1507-1515 Movement Disorders Movement Disorders, Wiley, 2005, 20 (11), pp.1507-15. ⟨10.1002/mds.20601⟩ Movement Disorders, 2005, 20 (11), pp.1507-15. ⟨10.1002/mds.20601⟩ |
ISSN: | 0885-3185 1531-8257 |
DOI: | 10.1002/mds.20601⟩ |
Popis: | International audience; Levodopa (L-dopa) and subthalamic nucleus (STN) stimulation treatments have been associated with both improvement and exacerbation of dysarthria in Parkinson's disease (PD). We report four cases illustrating variant responses of dysarthria to dopaminergic and STN stimulation therapies. Patients' motor disability and dysarthria were perceptually rated by the Unified Parkinson's Disease Rating Scale (UPDRS) in four conditions according to medication and STN stimulation. Dedicated software packages allowed acquisition and analysis of acoustic recordings. Case 1, who had a severe off period aphonia, experienced improvement of speech induced by both levodopa and STN stimulation. In Case 2, both treatments worsened speech due to the appearance of dyskinesias. Case 3 had a dysarthria exacerbation induced by STN stimulation with parameters above optimal levels, interpreted as current diffusion from the STN to corticobulbar fibers. In Case 4, dysarthria exacerbation occurred with stimulation at an electrode contact located caudally to the target, also arguing for current diffusion as a potential mechanism of speech worsening. The presented cases demonstrated variant effects in relation to L-dopa and STN stimulation on speech. It seems that motor speech subcomponents can be improved like other limb motor aspect, but that complex coordination of all speech anatomical substrates is not responsive to STN stimulation. These hypotheses may be helpful for better understanding and management of STN stimulation effects on motor speech and skeleton-motor subsystems. |
Databáze: | OpenAIRE |
Externí odkaz: |